Ergomed
Generated by Meeveem AI
"Global provider of clinical research, pharmacovigilance and audit services to pharma and biotech"
About Ergomed
Ergomed Group delivers specialist clinical research, pharmacovigilance and regulatory compliance services to pharmaceutical and biotechnology companies. Ergomed Clinical Research manages oncology, rare disease and complex trials; PrimeVigilance provides drug safety and medical information services; and ADAMAS Consulting undertakes GxP audits from early development through post-marketing surveillance. Prudentia adds safety database and systems expertise.
Founded in 1997 and headquartered in Guildford, the group supports drug development and the ongoing monitoring of medicines after approval. Its services reach researchers and patients in around 100 countries. PrimeVigilance alone serves more than 500 clients, while the group's complementary businesses help companies manage clinical development, patient safety and regulatory obligations.
Roles across the development lifecycle
The group brings together clinical research, drug safety, quality assurance and technology expertise. Its recruitment pages include biostatistics, clinical monitoring, trial administration, trial management and quality and compliance, reflecting the different disciplines involved in delivering and overseeing research.
1600
Team Members
1997
Founded
Contract Research
Sector
Hybrid
Work Environment